Related Experiment Video
Updated: Jun 19, 2026
08:45
A Visual Assay to Monitor T6SS-mediated Bacterial Competition
Published on: March 20, 2013
Type III secretion systems as targets for novel therapeutics
Vincent T Lee1, Jennifer L Kessler
1University of Maryland, Department of Cell Biology and Molecular Genetics, College Park, MD 20742, USA. vtlee@umd.edu
Idrugs : the Investigational Drugs Journal
|October 1, 2009
Summary
Targeting bacterial type III secretion systems (T3SS), crucial for pathogen virulence, offers a novel antivirulence therapy approach. This review explores T3SS inhibitor identification methods for developing new anti-infective treatments.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- Bacterial pathogens utilize conserved virulence factors to establish infections.
- The type III secretion system (T3SS) is a critical virulence factor enabling direct injection of effector proteins into host cells.
- Deficiencies in T3SS function lead to significant attenuation of bacterial pathogens in vivo.
Purpose of the Study:
- To provide an overview of strategies for identifying type III secretion system (T3SS) inhibitors.
- To highlight the potential of T3SS inhibitors as a novel therapeutic strategy against bacterial infections.
Main Methods:
- Review of existing literature on T3SS inhibitor discovery.
- Categorization of identified T3SS inhibitors based on their mechanisms of action.
- Analysis of the therapeutic potential of targeting T3SS.
Main Results:
- Several classes of T3SS inhibitors have been identified through various screening and rational design approaches.
- Inhibitors targeting different T3SS components and functions show promise in reducing bacterial virulence.
- The development of T3SS inhibitors represents a viable antivirulence strategy.
Conclusions:
- Targeting the T3SS offers a promising antivirulence approach to combat bacterial infections.
- Further research into T3SS inhibitor identification and development is warranted for novel therapeutic applications.
- T3SS inhibitors may reduce pathogen virulence without exerting direct selective pressure for resistance, unlike traditional antibiotics.
Related Concept Videos
01:17Gram-negative Bacterial Protein Secretion Systems
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:26Bacterial Translocation and Protein Secretion
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...